FDA issued a Warning Letter to Pharmakon Pharmaceuticals on 5/21/2015 as a result of this inspection.
483 Pharmakon Pharmaceuticals Mar 2014

483 Pharmakon Pharmaceuticals Mar 2014

Sarah Napier FDA, Emily Orban FDA, Sarah Meng FDA$119.00 - Available Now

FDA investigators audited the Pharmakon Pharmaceuticals - Noblesville, IN, United States facility and issued 11 inspectional observations (via FDA 483) on 13 Mar 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 11
  • Inspection end: 13 Mar 2014
  • Location: Noblesville, United States
  • FEI: 3008213711
Add To Cart